DiaGenic ASA

📍 Oslo, Norway🗓 Founded 1998👥 17 employees💰 Last funded 2005
Biotechnology Research🌐 diagenic.com
Website LinkedIn
DiaGenic is an innovative Norwegian diagnostic company that seeks to create value for patients, partners and investors by developing innovative and patient friendly in vitro diagnostic (IVD) products for early detection of diseases. The company’s proprietary concept implies that a disease evokes systemic responses in the blood unique for the disease, and which can be measured by using a blood sample. DiaGenic is a world leader in identifying gene expression signatures in blood and is focused on the development of IVD biomarker products in the field of Alzheimer’s disease. The company protects its technology through an extensive patent portfolio. DiaGenic is listed on the Oslo Stock Exchange. For more information please visit: www.diagenic.com
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
1998
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Sweden
1
Frequently asked questions
Who invested in DiaGenic ASA?
DiaGenic ASA has 1 investors on record on gritt.io and 1 late-stage investors.
When did DiaGenic ASA last raise funding?
The most recent investment in DiaGenic ASA recorded on gritt.io was in 2005.
When was DiaGenic ASA founded?
DiaGenic ASA was founded in 1998.
What industry is DiaGenic ASA in?
DiaGenic ASA operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is DiaGenic ASA based?
DiaGenic ASA is headquartered in Oslo, Norway.